1. Home
  2. NBB vs TOI Comparison

NBB vs TOI Comparison

Compare NBB & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen Taxable Municipal Income Fund of Beneficial Interest

NBB

Nuveen Taxable Municipal Income Fund of Beneficial Interest

HOLD

Current Price

$15.96

Market Cap

478.5M

Sector

Finance

ML Signal

HOLD

Logo The Oncology Institute Inc.

TOI

The Oncology Institute Inc.

HOLD

Current Price

$3.86

Market Cap

444.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBB
TOI
Founded
2009
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Medical/Nursing Services
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
478.5M
444.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NBB
TOI
Price
$15.96
$3.86
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$6.00
AVG Volume (30 Days)
73.9K
2.9M
Earning Date
01-01-0001
11-13-2025
Dividend Yield
8.64%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$461,039,000.00
Revenue This Year
N/A
$28.51
Revenue Next Year
N/A
$23.54
P/E Ratio
N/A
N/A
Revenue Growth
N/A
21.67
52 Week Low
$13.67
$0.17
52 Week High
$16.66
$4.88

Technical Indicators

Market Signals
Indicator
NBB
TOI
Relative Strength Index (RSI) 38.03 59.36
Support Level $15.99 $3.64
Resistance Level $16.32 $4.00
Average True Range (ATR) 0.19 0.21
MACD -0.01 0.11
Stochastic Oscillator 2.27 85.97

Price Performance

Historical Comparison
NBB
TOI

About NBB Nuveen Taxable Municipal Income Fund of Beneficial Interest

Nuveen Taxable Municipal Income Fund is a closed-end fund incorporated in the United States. Its primary objective is current income through investments in taxable municipal securities; the secondary objective is to seek enhanced portfolio value and total return. The fund invests a majority of its assets in a diversified portfolio of taxable municipal securities.

About TOI The Oncology Institute Inc.

The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.

Share on Social Networks: